Literature DB >> 31432130

ROCK inhibitor Y‑27632 protects rats against cerebral ischemia/reperfusion‑induced behavioral deficits and hippocampal damage.

Lihe Li1, Baoyang Liu1.   

Abstract

Cerebral ischemic injury is a major cause of death and long‑term disability worldwide that leads to neurological and behavioral deficits, and for which successful treatments are still lacking. Ras homolog family member A (RhoA) and Rho‑associated coiled‑coil containing protein kinase (ROCK) are associated with the growth of neurons and the movement of neuronal growth cones. RhoA/ROCK inhibitors have been demonstrated to promote the recovery of motor function following nerve injury, but the underlying mechanism requires further investigation. The present study aimed to investigate the effects of the ROCK inhibitor Y‑27632 on middle cerebral artery occlusion (MCAO)‑induced cerebral ischemic injury. Rats were randomly assigned to the Control, Y‑27632, MCAO + Vehicle or MCAO + Y‑27632 group. Firstly, infarct volume, cognitive ability and cerebral injury were assessed. Secondly, indicators of cerebral inflammation, oxidative stress and apoptosis were evaluated. Finally, the expression of recombinant glial fibrillary acidic protein (GFAP) and allograft inflammatory factor 1 (AIF1) in the brain were measured to assess the activation of astrocytes and microglia, respectively. The results showed that Y‑27632 effectively increased the survival rate and behavioral performance of rats, and attenuated the cerebral injury, oxidative stress and cerebral inflammation levels following MCAO. The disturbance in hippocampal neurons caused by MCAO was also alleviated following treatment with Y‑27632. Neuronal apoptosis was also decreased following Y‑27632 treatment, as demonstrated by the TUNEL assay and the expression levels of Caspases‑3, 8 and 9 and Bax/Bcl‑2 ratio. The levels of GFAP and AIF1 were increased by MCAO and further promoted by Y‑27632, indicating the activation of astrocytes and microglia. In conclusion, the present study offered evidence of a protective effect of Y‑27632 administration on cerebral ischemia/reperfusion induced behavioral and hippocampal damage by activating astrocytes and microglia.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31432130     DOI: 10.3892/mmr.2019.10584

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

Review 1.  Deregulated Protein Kinases: Friend and Foe in Ischemic Stroke.

Authors:  Sandeep Appunni; Deepika Gupta; Muni Rubens; Venkataraghavan Ramamoorthy; Himanshu Narayan Singh; Vishnu Swarup
Journal:  Mol Neurobiol       Date:  2021-09-22       Impact factor: 5.590

Review 2.  Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases.

Authors:  Qing Wang; Li-Juan Song; Zhi-Bin Ding; Zhi Chai; Jie-Zhong Yu; Bao-Guo Xiao; Cun-Gen Ma
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

3.  CREB Coactivator CRTC2 Plays a Crucial Role in Endothelial Function.

Authors:  Hideaki Kanki; Tsutomu Sasaki; Shigenobu Matsumura; Tomohiro Kawano; Kenichi Todo; Shuhei Okazaki; Kumiko Nishiyama; Hiroshi Takemori; Hideki Mochizuki
Journal:  J Neurosci       Date:  2020-10-30       Impact factor: 6.167

4.  H2S protects hippocampal neurons against hypoxia-reoxygenation injury by promoting RhoA phosphorylation at Ser188.

Authors:  Ye Chen; Jiyue Wen; Zhiwu Chen
Journal:  Cell Death Discov       Date:  2021-06-04

5.  Dexmedetomidine Attenuates Neurotoxicity in Developing Rats Induced by Sevoflurane through Upregulating BDNF-TrkB-CREB and Downregulating ProBDNF-P75NRT-RhoA Signaling Pathway.

Authors:  Yunxia Dong; Wei Hong; Zhiyin Tang; Yan Gao; Xiuying Wu; Hongtao Liu
Journal:  Mediators Inflamm       Date:  2020-06-20       Impact factor: 4.711

6.  Y-27632 Induces Neurite Outgrowth by Activating the NOX1-Mediated AKT and PAK1 Phosphorylation Cascades in PC12 Cells.

Authors:  So Yeong Park; Jeong Mi An; Jeong Taeg Seo; Su Ryeon Seo
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.